Journal of the Peripheral Nervous System

Papers
(The median citation count of Journal of the Peripheral Nervous System is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
65
46
Abstracts38
30
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain26
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”23
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy23
PNS Abstracts 202321
Toxic medications in Charcot–Marie–Tooth patients: A systematic review19
18
Nerve ultrasound as a screening tool for inherited sensory neuronopathy16
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort15
Ofatumumab for treating autoimmune nodopathy15
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders15
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice14
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study14
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy14
Issue Information13
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy12
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy12
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials12
Issue Information11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy11
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version11
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods11
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency10
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis10
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei10
Techniques for the standard histological and ultrastructural assessment of nerve biopsies10
Issue Information10
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis9
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy9
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A9
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia8
8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision8
Issue Information8
Issue Information8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes8
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)8
8
Issue Information8
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers7
Issue Information7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response7
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy7
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po6
ABSTRACT6
6
The autoimmune vulnerability of the node of Ranvier6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”6
6
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study5
5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”5
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease4
Anxiety and depression in small fiber neuropathy4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study4
Issue Information4
Issue Information4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort4
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review4
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children3
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis3
3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor3
Issue Information3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury3
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal3
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations3
Issue Information3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy3
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgMRODS3
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome3
3
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria3
Issue Information3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years3
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies3
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves3
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders3
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients2
Unusual upper limb features in SORD neuropathy2
Identification of cellular and noncellular components of mature intact human peripheral nerve2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy2
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN12
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review2
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease2
Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement2
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?2
2
Abstract2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy2
Leptospirosis‐induced acute acquired inflammatory neuropathy2
Issue Information2
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity2
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity2
Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges1
1
Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape1
Issue Information1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome1
1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents1
Abstract1
1
Issue Information1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A11
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”1
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset1
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?1
Serum neurofilament light chain measurements following nerve trauma1
Issue Information1
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study1
Sural nerve biopsy utility by masked assessment of individual histologic preparations1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy1
Intrathecal Antibody Synthesis in Autoimmune Nodopathy1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review1
Normal structure and pathological features in peripheral neuropathies1
Issue Information1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy1
Laura Feltri: In memoriam1
Pseudodominant Inheritance of Biallelic RFC1 Expansions—Revisiting the 3p22‐p24 HSN1B Locus1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A1
Issue Information1
Issue Information1
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response1
Motor Neuropathy in a Patient With Mitochondrial Disease and a Novel TTC19 Variant: An Underrecognized Phenotypic Feature1
0.085044145584106